Your session is about to expire
← Back to Search
Doxycycline Post-Exposure Prophylaxis for STIs (DOXY-PEP Trial)
DOXY-PEP Trial Summary
This trial looks at combining doxycycline with antiretrovirals to create a single-dose event-driven strategy to protect against HIV & STIs. Participants will be recruited through face-to-face & online engagements.
DOXY-PEP Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.DOXY-PEP Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I haven't used certain medications or treatments for my condition in the last 90 days.I have kidney disease or my kidney function is low.I have hepatitis or liver disease.I am between 18 and 59 years old.I am willing to consistently use condoms during the study.I am not taking and do not plan to take doxycycline or similar antibiotics.I was assigned male or female at birth.I am HIV-positive, on stable treatment, with undetectable virus levels and a healthy immune system.I am willing to provide blood, urine, and other samples, and undergo biopsy procedures.
- Group 1: Doxycycline 100 mg
- Group 2: Doxycycline 200 mg
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is Doxycycline 100 mg a hazard to patients if taken as prescribed?
"The safety of Doxycycline 100 mg has been verified through Phase 4 trials, resulting in a score of 3 being attributed to it."
What is the projected participant count for this clinical trial?
"Affirmative. According to information hosted on clinicaltrials.gov, this research is recruiting participants at the current moment in time. The trial was initially posted on May 31st 2023 and had its latest update on June 8th of that same year; 40 patients are meant to be enrolled from one medical facility."
Are there any open slots still available for individuals to take part in this trial?
"Per clinicaltrials.gov, this study is currently enrolling participants. The original listing was published on May 31st 2023 and the most recent edits were made on June 8th of that same year."
Am I eligible to partake in this clinical trial?
"To be selected for this trial, 40 individuals must have a sexually transmitted disease and reside in the 18 to 59 age range."
Could participants aged 35 and above partake in this trial?
"This trial has a limited age range for participation, with the cut offs at 18 and 59 years old. However, other studies are available for children under 18 as well as adults over 65."
Share this study with friends
Copy Link
Messenger